CCL2 and myeloid sarcoma: Since astrocyte-derived CCL2 is a prominent factor involved in the attraction of leukocytes through the BBB in WML in MS [25,26], the relative absence of CCL2 in GML may subsequently explain the lack of infiltrating immune cells in this type of lesion.